Does prior systemic chemotherapy exposure influence subsequent response to ROS1 tyrosine kinase inhibitors (TKIs) in ROS1-rearranged non-small-cell lung cancer? Learn more in this #JCOPO systematic review.

Read the article. https://bit.ly/4zc5BHH

#NSCLC

#JCOPO Editor-in-Chief Emeritus Dr James Ford & @ascocancer.bsky.social TAPUR Study Founding PI Dr Richard Schilsky discuss the 10-year anniversary of the Targeted Agent and Profiling Utilization Registry (TAPUR)™ Study & its relationship w/ the journal. Listen to the podcast. https://bit.ly/4yPsiRQ

Generalized Evolutionary Classifier for Evolutionary Guided Precision Medicine ascopubs.org/doi/10.1200/... #JCOPO #OpenAccess

Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation ascopubs.org/doi/10.1200/... #JCOPO #PrecisionOnc #JCOJournals #OpenAccess

Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial ascopubs.org/doi/10.1200/...
#JCOPO #JCOJournals #PrecisionOncology #OpenAccess

Out now in #JCOPO: Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival #https://ascopubs.org/doi/10.1200/PO-24-00603
#precisiononcology, #JCOJournals, #openaccess

Parents' Experiences With and Preferences for Receiving Information About Tumor Genomic Sequencing: Findings From a Qualitative Study and Implications for Practice #JCOPO #precisiononcology #oncsky #caregivers #JCOJournals ascopubs.org/doi/10.1200/...

Check out the latest #TAPUR study paper in #JCOPO: Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. Read the full article: https://bit.ly/4cVvaUU

JCO Precision Oncology would like to welcome our newest Associate Editor Matthew B. Yurgelun, MD, of Dana-Farber Cancer Institute, Boston, Mass.

#JCOPO @mattyurgelun.bsky.social

A new original report in #JCOPO provides valuables insights into the genomic landscape and prognostic biomarkers of advanced ESCC, which can guide future research toward more reliable biomarkers and targeted strategies.

Read the article: https://ascopubs.org/doi/10.1200/PO-25-00971
#esocsm

We are proud to name Zsofia Stadler, MD from
@mskcancercenter.bsky.social the next Editor-in-Chief of JCO Precision Oncology starting July 1st. Dr. Stadler’s expertise will drive the integration of genomics & AI into cancer research for improved patient outcomes. Read more: bit.ly/4aoLPyZ
#JCOPO

We're thrilled to be here on BlueSky to bring you the latest practice-changing oncology research from all six JCO Journals! Follow-us for great content from #JCO, #JCOOP, #JCOGO, #JCOPO, #JCOCCI, & #JCOOA.

In this JCOPO ASCO podcast, JAX's Jens Rueter discusses his paper, "The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State," and the successes of MCGI:
sites.libsyn.com/427415/JCOpr...

Kann mir jemand erklären, wie man zum Urteil kommt, dass eine Jugendbande, die politische Parolen verbreitet, das nicht aus politischen Motiven tue?

archive.is/JCOpO